Basic Science Research
Chad J. Roy, PhD, MSPH
Chad J. Roy, Ph.D. presently is an Associate Professor of Microbiology and Immunology and a core scientist at the Tulane National Primate Research Center, Division of Microbiology. His primary faculty appointment is within the Tulane University School of Medicine Department of Microbiology and Immunology. He also serves as the Director of the Infectious Disease Aerobiology scientific core located within the Division of Microbiology at the TNPRC. Dr. Roy is a career aerobiologist with a focus on infectious diseases; he has worked for more than 15 years in the field, the last seven of which have been spent at the TNPRC. He has published over 50 PUBMED-indexed articles and a number of other scholarly publications including a book chapter on aerobiology methods which since its publication is considered by many as the standard in the scientific field. He serves on the editorial board (associate editor) of Frontiers in Cellular and Infection Microbiology.
His research focuses on respiratory health and the aerobiology of airborne infectious diseases; specifically he has worked on gaining a better understanding of aerosol infection in the context of the development and application of preclinical disease models; the majority of his efforts have been directed in the use of the nonhuman primate for this purpose. The practical application of this research has been and continues to be enabling advanced pathogenesis studies as well as medical product evaluation. His laboratory works with a diverse array of infectious and highly toxic agents considered biological threat agents rather than a singular focus on a particular class or agent. Essentially all of the research in Dr. Roy's laboratory is performed within a high containment (BSL-3) environment. The inclusion of such a wide number of biological threat agents in his research program has been the result of extensive, highly collaborative studies between a number of extramural laboratories and his laboratory. Affiliate scientists have leveraged this collaboration as a complement to their own research programs, taking full advantage of the relationship to the Roy laboratory for access to this unique scientific resource. His current research portfolio includes evaluation studies of antivirals in aerosol-induced poxviral infections, and evaluation of optimized monoclonal antibodies as therapeutic agents for toxin (SEB and ricin) exposure. He is also involved in investigation of the immunogenicity and protective efficacy of virally-vectored vaccines against aerosol-initiated alphaviral disease. There are also significant efforts ongoing in his laboratory to develop disease models for biothreat agents such as Burkholderia pseudomallei and Rickettsia prowazekii in the nonhuman primate.
Click here to see Dr. Roy's curriculum vitae.
1430 Tulane Ave, New Orleans, LA 70112 504-988-2250 email@example.com